Patents Assigned to Maelor Pharmaceuticals Limited
  • Patent number: 7166303
    Abstract: Propofol solubilised in aqueous micellar preparations of poloxamers is stable at low concentrations and that such preparations are effective administration forms for Propofol.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: January 23, 2007
    Assignee: Maelor Pharmaceuticals Limited
    Inventors: John Meadows, James David Du Mayne
  • Patent number: 7083806
    Abstract: The present invention relates to hydrogels, in particular gels for use on wounds. The invention provides a gel which is better able to maintain viscosity and gel integrity when exposed to wound exudates, for example. A hydrogel comprising a poloxamer is provided. Further provided is a hydrogel comprising a cross-linked gellant, and water wherein the hydrogel comprises a poloxamer and has the capacity to absorb at least 50% further water in addition to the water already present. Suitable gellants are pharmaceutically acceptable, cross-linked, hydrophilic polymers. Hydrogels of the present invention are useful in medicine, or therapy and are in particular useful in application to epithelial lesions, especially wounds, such as accidental or surgical wounds.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: August 1, 2006
    Assignee: Maelor Pharmaceuticals Limited
    Inventors: Mark Geoffrey Rippon, John Meadows